Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utilization of Artificial Intelligence for the Development of an EUS-convolution Neural Network Model Trained to Differentiate Pancreatic Cancer From Other Pancreatic Solid Lesions

NCT05476978 is registered in ClinicalTrials.gov with Huazhong University of Science and Technology as lead sponsor.

NCT NCT05476978
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05476978 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utilization of Artificial Intelligence for the Development of an EUS-convolution Neural Network Model Trained to Differentiate Pancreatic Cancer From Other Pancreatic Solid Lesions
Lead sponsor
Huazhong University of Science and Technology
Phase
Observational
Overall status
Completed
Start date
July 1, 2022
Completion date
January 24, 2024
Enrollment
130 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune pancreatitis, pancreatic ductal adenocarcinoma, pancreatic neuroendocrine tumor, pancreatitis, chronic